Passage Bio, Inc.
PASG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $22 | $35 | $129 |
| Short-Term Investments | $39 | $93 | $155 | $187 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $2 |
| Total Curr. Assets | $79 | $118 | $197 | $325 |
| Property Plant & Equip (Net) | $23 | $32 | $42 | $24 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $4 | $6 |
| Total NC Assets | $24 | $33 | $47 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $102 | $151 | $244 | $355 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $4 | $9 |
| Short-Term Debt | $4 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $11 | $7 | $0 | $1 |
| Total Curr. Liab. | $19 | $16 | $18 | $29 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $7 |
| Total NC Liab. | $22 | $23 | $24 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $25 | $26 | $27 | $0 |
| Total Liabilities | $41 | $39 | $42 | $36 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$659 | -$594 | -$492 | -$356 |
| AOCI | $0 | -$0 | -$1 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $61 | $111 | $201 | $319 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $102 | $151 | $244 | $355 |
| Net Debt | -$34 | -$22 | -$35 | -$129 |